Thousand Oaks, CA, United States of America

Ron C Kelly

This inventor holds 15 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Amgen Inc., Cytokinetics, Inc., Other. Active years: 2011-2026.

USPTO Granted Patents = 15 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 9)

EPO Patents = 2 (Patent Applications = 11)

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 49(Granted Patents)

Location History:

San Mateo, CA (US) (2011)
Westlake Village, CA (US) (2022 - 2023)
Thousand Oaks, CA (US) (2022 - 2024)

Company Filing History:

1 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12622918 - Formulations and dosages for administering a compound that inhibits MCL1 protein (2026-05-12),

2. 12612366 - Salts and crystal forms of omecamtiv mecarbil (2026-04-28),

3. 12473329 - Methods directed to crystalline biomolecules (2025-11-18),

4. 12421234 - Solid state forms (2025-09-23),

5. 12415806 - Solid state forms (2025-09-16),

6. 12398133 - Solid state forms (2025-08-26),

7. 12252486 - Solid state forms (2025-03-18),

8. 12187700 - Polymorphs and cocrystals of a cardiac troponin activator (2025-01-07),

9. 12000915 - Method for conducting solid state NMR on macromolecule-containing solid state formulations (2024-06-04),

10. 11958882 - Methods directed to crystalline biomolecules (2024-04-16),

11. 11926592 - Salts and crystal forms of omecamtiv mecarbil (2024-03-12),

12. 11827635 - Solid state forms (2023-11-28),

13. 11465969 - Salts and crystal forms of omecamtiv mecarbil (2022-10-11),

14. 11236091 - Solid state forms (2022-02-01),

15. 8084605 - Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor (2011-12-27),

Title: Ron C Kelly: Innovator in Crystalline Biomolecules

Introduction

Ron C Kelly is a prominent inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biomolecular research, holding a total of 15 patents. His work primarily focuses on methods related to crystalline biomolecules, which have important applications in pharmaceuticals and biotechnology.

Latest Patents

Among his latest patents, one notable invention is directed to methods for preparing a composition comprising crystalline biomolecules, such as crystalline antibodies. This method involves forming a fluidized bed of crystalline biomolecules using a counter-flow centrifuge to exchange buffer and concentrate the biomolecules in a solution. Additionally, he has developed methods for detecting both crystalline and amorphous biomolecules in various samples. Another significant patent includes the provision of crystalline and amorphous forms of a specific compound, which has implications for treating diseases mediated by KRAS G12C inhibition.

Career Highlights

Throughout his career, Ron C Kelly has worked with leading companies in the biotechnology sector, including Amgen Inc. and Cytokinetics, Inc. His expertise in biomolecular research has positioned him as a valuable asset in these organizations, contributing to advancements in drug development and therapeutic solutions.

Collaborations

Ron has collaborated with notable professionals in his field, including Mary Chaves and Darren Leonard Reid. These partnerships have fostered innovation and have been instrumental in the successful development of his patented technologies.

Conclusion

Ron C Kelly's contributions to the field of crystalline biomolecules exemplify his dedication to innovation and research. His patents and collaborations continue to influence advancements in biotechnology and pharmaceuticals.